NCT06069232 Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
| NCT ID | NCT06069232 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Aortic Valve Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2021-03-01 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2021-03-01 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a multicenter cohort study including patients diagnosed with aortic valve disease during hospitalization, including aortic insufficiency and aortic valve stenosis. The primary outcome of the study was all-cause death, and the secondary outcome was cardiovascular events. Through follow-up observation, the prognostic risk factors of patients with aortic disease were evaluated, and a prognostic model was constructed to guide clinical decision-making.
Eligibility Criteria
Inclusion Criteria: * age ≥ 18 * diagnosed as aortic valve disease Exclusion Criteria: * aortic valve replacement at baseline
Contact & Investigator
xiaodong zhuang, PhD
PRINCIPAL INVESTIGATOR
First Affiliated Hospital, Sun Yat-Sen University
Frequently Asked Questions
Who can join the NCT06069232 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Aortic Valve Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06069232 currently recruiting?
Yes, NCT06069232 is actively recruiting participants. Contact the research team at zhuangxd3@mail.sysu.edu.cn for enrollment information.
Where is the NCT06069232 trial being conducted?
This trial is being conducted at Guangzhou, China, Guangzhou, China, Jieyang, China, Shantou, China and 3 additional locations.
Who is sponsoring the NCT06069232 clinical trial?
NCT06069232 is sponsored by Sun Yat-sen University. The principal investigator is xiaodong zhuang, PhD at First Affiliated Hospital, Sun Yat-Sen University. The trial plans to enroll 2,000 participants.